Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3081)
All Articles published online
|
Oct 15, 2004 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gao P, Zhou GY, Liu Y, Li JS, Zhen JH, Yuan YP. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance. World J Gastroenterol 2004; 10(20): 2936-2939 [PMID: 15378768 DOI: 10.3748/wjg.v10.i20.2936] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i20/2936.htm |
| Number | Citing Articles |
| 1 |
Thorsten Wiech, Elisabeth Nikolopoulos, Silke Lassman, Timo Heidt, Anja Schöpflin, Mario Sarbia, Martin Werner, Yuko Shimizu, Emna Sakka, Tadamasa Ooka, Axel zur Hausen. Cyclin D1 expression is induced by viral BARF1 and is overexpressed in EBV-associated gastric cancer. Virchows Archiv 2008; 452(6): 621 doi: 10.1007/s00428-008-0594-9
|
| 2 |
Yu-Fen Lin, Ming-Shiang Wu, Chia-Che Chang, Sheng-Wei Lin, Jaw-Town Lin, Yuh-Ju Sun, Ding-Shinn Chen, Lu-Ping Chow. Comparative Immunoproteomics of Identification and Characterization of Virulence Factors from Helicobacter pylori Related to Gastric Cancer . Molecular & Cellular Proteomics 2006; 5(8): 1484 doi: 10.1074/mcp.M600111-MCP200
|
| 3 |
Yue Liu, Zhouyue Jiang, Hongwei Yang, Jingyi Yuan, Jiali Zeng, Jiayan Wu, Zhijian Xu. Gui Shao Tea Extracts Inhibit Gastric Cancer Growth in Vitro and in Vivo and Prolong Survival in Nude Mice. Frontiers in Bioscience-Landmark 2022; 27(8) doi: 10.31083/j.fbl2708250
|
| 4 |
Jing Wang, Wei Su, Taotao Zhang, Shasha Zhang, Huiwen Lei, Fengdie Ma, Maoning Shi, Wenjing Shi, Xiaodong Xie, Cuixia Di. Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation. Cell Death & Disease 2023; 14(4) doi: 10.1038/s41419-023-05763-7
|
| 5 |
Haichao Xia, Yanran Huang, Lulu Zhang, Lijuan Luo, Xiaoxuan Wang, Qiuping Lu, Jingtao Xu, Chunmei Yang, Habu Jiwa, Shiqiong Liang, Liping Xie, Xiaoji Luo, Jinyong Luo. Inhibition of Macropinocytosis Enhances the Sensitivity of Osteosarcoma Cells to Benzethonium Chloride. Cancers 2023; 15(3): 961 doi: 10.3390/cancers15030961
|
| 6 |
Min Deng, Chao Zeng, Xihong Lu, Xiusheng He, Ruixin Zhang, Qinwei Qiu, Guopei Zheng, Xiaoting Jia, Hao Liu, Zhimin He. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop. Cancer Letters 2017; 403: 175 doi: 10.1016/j.canlet.2017.06.006
|
| 7 |
Qunyan Yu, Ewa Sicinska, Yan Geng, Marie Ahnström, Agnieszka Zagozdzon, Yinxin Kong, Humphrey Gardner, Hiroaki Kiyokawa, Lyndsay N. Harris, Olle Stål, Piotr Sicinski. Requirement for CDK4 kinase function in breast cancer. Cancer Cell 2006; 9(1): 23 doi: 10.1016/j.ccr.2005.12.012
|
| 8 |
Qunqing Liu, Guiying Zhang. Expressions of cyclin D1 and p27kip1 in carcinogenesis of stomach mucosa. The Chinese-German Journal of Clinical Oncology 2008; 7(8): 469 doi: 10.1007/s10330-008-0060-9
|
| 9 |
R. Sarkar, I. A. Hunter, R. Rajaganeshan, S. L. Perry, P. Guillou, D. G. Jayne. Expression of cyclin D2 is an independent predictor of the development of hepatic metastasis in colorectal cancer. Colorectal Disease 2010; 12(4): 316 doi: 10.1111/j.1463-1318.2009.01829.x
|
| 10 |
Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer. Medical Oncology 2016; 33(5) doi: 10.1007/s12032-016-0754-8
|
| 11 |
Georgia Levidou, Angelica A. Saetta, Maria Karlou, Irene Thymara, Harris Pratsinis, Petros Pavlopoulos, Dimitrios Isaiadis, Kalliopi Diamantopoulou, Efstratios Patsouris, Penelope Korkolopoulou. D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance. Journal of Cancer Research and Clinical Oncology 2010; 136(10): 1563 doi: 10.1007/s00432-010-0814-y
|
| 12 |
Jian Yang, Yawen Chen, Yang He, Mingxu Da. YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistance. Drug Development Research 2024; 85(2) doi: 10.1002/ddr.22179
|
| 13 |
Marek Mazurek, Monika Szewc, Monika Z. Sitarz, Ewa Dudzińska, Robert Sitarz. Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer. Cancers 2024; 16(18): 3163 doi: 10.3390/cancers16183163
|
| 14 |
Tamotsu Sugai, Wataru Habano, Masaki Endoh, Yasuhiro Konishi, Risaburo Akasaka, Minoru Toyota, Hiroo Yamano, Keisuke Koeda, Go Wakabayashi, Kazuyuki Suzuki. Molecular analysis of gastric differentiated‐type intramucosal and submucosal cancers. International Journal of Cancer 2010; 127(11): 2500 doi: 10.1002/ijc.25271
|
| 15 |
Phillip Stahl, Carsten Seeschaaf, Patrick Lebok, Asad Kutup, Maximillian Bockhorn, Jakob R Izbicki, Carsten Bokemeyer, Ronald Simon, Guido Sauter, Andreas H Marx. Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0231-4
|
| 16 |
Ichiro Kishimoto, Hiroyuki Mitomi, Yasuo Ohkura, Hideki Kanazawa, Naoshi Fukui, Masahiko Watanabe. Abnormal Expression of p16INK4a, Cyclin D1, Cyclin‐Dependent Kinase 4 and Retinoblastoma Protein in Gastric Carcinomas. Journal of Surgical Oncology 2008; 98(1): 60 doi: 10.1002/jso.21087
|
| 17 |
Tianyi Wu, Lizhao Wu. The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.655630
|
| 18 |
Shinji Takasu, Tetsuya Tsukamoto, Toshikazu Ushijima, Satoshi Yamashita, Naotaka Ogasawara, Hisayo Ban, Tokuma Yanai, Toshiaki Masegi, Masae Tatematsu. Cyclin D1 overexpression in N-methyl-N′-nitro-N-nitrosoguanidine-induced rat gastric adenocarcinomas. Experimental and Toxicologic Pathology 2007; 59(3-4): 171 doi: 10.1016/j.etp.2007.06.005
|
| 19 |
R Cahyanur, AP Utari, N Rahadiani. Cyclin D1 Expression, Clinicopathological Characteristics, and 2-Year Survival Rate of Gastric Cancer in Cipto Mangunkusumo General Hospital. Nigerian Journal of Clinical Practice 2023; 26(8): 1057 doi: 10.4103/njcp.njcp_222_22
|
| 20 |
Orsolya Galamb, Ferenc Sipos, Bela Molnar, Dominika Szoke, Sandor Spisak, Zsolt Tulassay. Evaluation of malignant and benign gastric biopsy specimens by mRNA expression profile and multivariate statistical methods. Cytometry Part B: Clinical Cytometry 2007; (5): 299 doi: 10.1002/cyto.b.20189
|
| 21 |
Ghazal Basirinia, Muhammad Ali, Albert Comelli, Alessandro Sperandeo, Sebastiano Piana, Pierpaolo Alongi, Costanza Longo, Domenico Di Raimondo, Antonino Tuttolomondo, Viviana Benfante. Theranostic Approaches for Gastric Cancer: An Overview of In Vitro and In Vivo Investigations. Cancers 2024; 16(19): 3323 doi: 10.3390/cancers16193323
|
| 22 |
Julita Machlowska, Ryszard Maciejewski, Robert Sitarz. The Pattern of Signatures in Gastric Cancer Prognosis. International Journal of Molecular Sciences 2018; 19(6): 1658 doi: 10.3390/ijms19061658
|
| 23 |
Ahrum Min, Jung Eun Kim, Yu-Jin Kim, Jee Min Lim, Seongyeong Kim, Jin Won Kim, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Yung-Jue Bang, Seock-Ah Im. Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells. Cancer Letters 2018; 430: 123 doi: 10.1016/j.canlet.2018.04.037
|
| 24 |
Julita Machlowska, Jacek Baj, Monika Sitarz, Ryszard Maciejewski, Robert Sitarz. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. International Journal of Molecular Sciences 2020; 21(11): 4012 doi: 10.3390/ijms21114012
|
| 25 |
Tae‐Wang Kim, So‐Young Youm, Sang‐Kyung Shin, Dae Joong Kim, Jin Tae Hong, Youngsoo Kim, Sang‐Yoon Nam, Byeongwoo Ahn. Chemopreventive effects of elm tree bark extract onHelicobacter pylori‐associated mouse gastric carcinogenesis. Basic and Applied Pathology 2012; 5(2): 31 doi: 10.1111/j.1755-9294.2012.01125.x
|
| 26 |
Konstantinos Triantafyllou, Vasilios Papadopoulos, Theodoras Emanouil, Paraskevas Gkolfakis, Vasileia Damaskou, Georgios Tziatzios, Ioannis G. Panayiotides, Irene Vafiadis, Spiros D. Ladas. Eradication ofHelicobacter pyloriInfection Restores ki67, p53, and Cyclin D1 Immunoreactivity in the Human Gastric Epithelium. Clinical Medicine Insights: Gastroenterology 2016; 9: CGast.S38330 doi: 10.4137/CGast.S38330
|
| 27 |
Lucimari Bizari, Aldenis Albanese Borim, Kátia Ramos Moreira Leite, Fernanda de Toledo Gonçalves, Patrícia Maluf Cury, Eloiza Helena Tajara, Ana Elizabete Silva. Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers. Cancer Genetics and Cytogenetics 2006; 165(1): 41 doi: 10.1016/j.cancergencyto.2005.08.031
|
| 28 |
JunYu Wang, Qi Wang, Yong Cui, Zhen Yang Liu, Wei Zhao, Chun Lin Wang, Yan Dong, LiJun Hou, GuoHan Hu, Chun Luo, Juxiang Chen, YiCheng Lu. Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. Journal of Neuro-Oncology 2012; 106(3): 473 doi: 10.1007/s11060-011-0692-4
|
| 29 |
Elisa Ventura, Antonio Giordano. Reference Module in Life Sciences. 2019; doi: 10.1016/B978-0-12-809633-8.90189-4
|
| 30 |
Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha. Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer. Current Issues in Molecular Biology 2022; 44(3): 1395 doi: 10.3390/cimb44030093
|
| 31 |
Hsiang‐Lin Tsai, Yung‐Sung Yeh, Yu‐Tang Chang, I‐Ping Yang, Chih‐Hung Lin, Chao‐Hung Kuo, Suh‐Hang Juo, Jaw‐Yuan Wang. Co‐existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I–III colorectal cancer patients after curative resection. Journal of Surgical Oncology 2013; 107(2): 148 doi: 10.1002/jso.23243
|
| 32 |
Chenwei Yuan, Xingwu Zhu, Yang Han, Chenlong Song, Chenchen Liu, Su Lu, Meng Zhang, Fudong Yu, Zhihai Peng, Chongzhi Zhou. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0294-2
|
| 33 |
Masayoshi Yasui, Hirofumi Yamamoto, Chew Yee Ngan, Bazarragchaa Damdinsuren, Yurika Sugita, Hiroki Fukunaga, Jinyu Gu, Makiko Maeda, Ichiro Takemasa, Masataka Ikeda, Yasushi Fujio, Mitsugu Sekimoto, Nariaki Matsuura, I. Bernard Weinstein, Morito Monden. Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor–Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization. Clinical Cancer Research 2006; 12(15): 4720 doi: 10.1158/1078-0432.CCR-05-1213
|
| 34 |
Ai Jia, Jun Gong, Yingchao Li, Zhiming Hao, Xinming Chang, Fei Dai, Bing Yu. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China. Scandinavian Journal of Gastroenterology 2008; 43(11): 1353 doi: 10.1080/00365520802158622
|
| 35 |
JIN-HEE SEO, EUI-SUK JEONG, KYOUNG-SUN LEE, SEUNG-HO HEO, DONG-GU JEONG, YANG-KYU CHOI. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil. International Journal of Oncology 2013; 43(6): 2007 doi: 10.3892/ijo.2013.2119
|
| 36 |
Dárcio Matenhauer Lehrbach, Ivan Cecconello, Ulysses Ribeiro Jr, Vera Luiza Capelozzi, Alexandre Muxfeldt Ab'Saber, Venâncio Avancini Ferreira Alves. Adenocarcinoma of the esophagogastric junction: relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions. Arquivos de Gastroenterologia 2009; 46(4): 315 doi: 10.1590/S0004-28032009000400013
|
| 37 |
Amal M. Mohamed, Tarek F. Elwakil, Ibrahim M. Taher, Mohamed M. Elbarbary, Hesham F. Kayed, Hassan A. Hussein, Ola M. Eid. Cyclin D1 gene amplification in proliferating haemangioma. Cell and Tissue Research 2009; 338(1): 107 doi: 10.1007/s00441-009-0858-y
|
| 38 |
Jin-Hee Seo, Eui-Suk Jeong, Yang-Kyu Choi. Therapeutic effects of lentivirus-mediated shRNA targeting of cyclin D1 in human gastric cancer. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-175
|
| 39 |
Gang Cheng, Leiming Zhang, Wenying Lv, Chao Dong, Yaming Wang, Jianning Zhang. Overexpression of cyclin D1 in meningioma is associated with malignancy grade and causes abnormalities in apoptosis, invasion and cell cycle progression. Medical Oncology 2015; 32(1) doi: 10.1007/s12032-014-0439-0
|
| 40 |
Torsten K. Roepke, Kerry Purtell, Elizabeth C. King, Krista M. D. La Perle, Daniel J. Lerner, Geoffrey W. Abbott, Xin-yuan Guan. Targeted Deletion of Kcne2 Causes Gastritis Cystica Profunda and Gastric Neoplasia. PLoS ONE 2010; 5(7): e11451 doi: 10.1371/journal.pone.0011451
|